Replies to post #86043 on Biotech Values

[DewDiligence]

IGIV factoid from TLCR CC: Approximately 1/3 of US sales of IGIV are for chronic inflammatory demyelinating polyneuropathy (CIDP), an indication for which only TLCR’s Gamunex has an FDA label.